Hemotune raises CHF 14 million with Belmondo, VP Venture Partners, Occident, Hemex and EFI Lake Geneva Ventures
01 March 2024
01 March 2024
Total investments received (USD): 30.05m
Round value (USD): 15.76m
Round investors:
Hemex
OCCIDENT
Zürcher Kantonalbank
VP Venture Partners
EFI Lake Geneva Ventures
Belmondo
Company: Hemotune AG
Industry:
Biotech
Health services
Related deals
Vandria announced the second closing of its Series A financing with Hevolution Foundation and Dolby Family Ventures joined by ND Capital.
Investments
09 August 2024
Stalicla raised $17.4m ($3.8m in a credit facility) in Series B funding led by SPRIM Global Investments
Investments
09 January 2024
Belgium
Netherlands
Austria
Germany
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom